Can hospitals boost vaccine access for the most vulnerable?
NCT ID NCT07391046
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will test a new way to offer vaccines to vulnerable patients—those with chronic diseases or weakened immune systems—during hospital visits. Researchers will see if offering, prescribing, and giving vaccines in the hospital increases how many people get vaccinated. The goal is to make it easier for high-risk patients to stay protected against preventable diseases.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this model could make it easier for vulnerable patients to get recommended vaccines during hospital visits, potentially preventing serious infections.
- What could go wrong
- This is an observational study, not a test of a new treatment. It only measures how well the vaccination program works, not whether vaccines prevent disease. Results may not apply to other hospitals.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASPLENIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A good Night's sleep: could a simple program ease Cancer's toll on rest?
- Smart sensors at home could spot frailty early and lend a helping hand
- Could sitting up make radiation therapy more comfortable?
- Can we predict dangerous side effects when combining radiation and immunotherapy?
- Family history as a shield: can culturally tailored guidance cut cancer risk?
- Aging kidneys under the microscope: could a simple test predict failure?